Home › Trial NCT06570031
ONO-4578-06:Phase I Study of ONO-4578 and Letrozole Plus CDK4 /6 Inhibitors in Breast Cancer
- Trial IDNCT06570031
- StatusCompleted
- PhasePhase 1
- Study typeInterventional
- SponsorOno Pharmaceutical Co., Ltd.
- Enrollment46
- Start date2021-11-09
- ConditionsHormone Receptor-positive Breast Cancer · HER2-negative Breast Cancer · Metastatic Breast Cancer · Recurrent Breast Cancer
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.